{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T14:51:44Z","timestamp":1774968704066,"version":"3.50.1"},"reference-count":14,"publisher":"BMJ","issue":"4","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Support Palliat Care"],"accepted":{"date-parts":[[2023,11,15]]},"published-print":{"date-parts":[[2025,7]]},"abstract":"<jats:sec><jats:title>Aim<\/jats:title><jats:p>To assess the mortality rate and the use of palliative sedation (PS) in an advanced long-standing acute palliative care unit (APCU)<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>The charts of patients who died and eventually received PS, consecutively admitted to the APCU for 4 years, were reviewed. Patients\u2019 characteristics and symptom intensity were recorded at admission, 3\u2009days before death and the day before death (T0, T-3, T-end, respectively). For patients who were administered midazolam for PS, initial and final doses of drugs, as well as duration of PS until death, were recorded.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>One hundred and forty-eight patients died in APCU (8.9%), and 45 of them (30.4%) received PS. Younger patients and those reporting high levels of dyspnoea at T-3 and T-end were more likely to be sedated (p=0.002, p=0.013 and 0.002, respectively). The mean duration of PS was 27.47\u2009hours. Mean initial and final doses of midazolam were 35.45\u2009mg\/day (SD 19.7) and 45.57\u2009mg\/day (SD 20.6), respectively (p=0.001).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Mortality rate in APCU was very low. As a percentage of the number of deaths, PS rate was similar to that reported in other settings. PS does not seem to accelerate impending death.<\/jats:p><\/jats:sec>","DOI":"10.1136\/spcare-2023-004669","type":"journal-article","created":{"date-parts":[[2023,12,28]],"date-time":"2023-12-28T18:20:11Z","timestamp":1703787611000},"page":"526-529","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":8,"title":["Mortality rate and palliative sedation in an acute palliative care unit"],"prefix":"10.1136","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9859-6487","authenticated-orcid":false,"given":"Sebastiano","family":"Mercadante","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5581-4114","authenticated-orcid":false,"given":"Alessio","family":"Lo Cascio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandra","family":"Casuccio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2023,12,28]]},"reference":[{"key":"2025062705050659000_15.4.526.1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.24.6397"},{"key":"2025062705050659000_15.4.526.2","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1002\/cncr.32738","article-title":"State of palliative care services at US cancer centers: an updated national survey","volume":"126","author":"Hui","year":"2020","journal-title":"Cancer"},{"key":"2025062705050659000_15.4.526.3","doi-asserted-by":"publisher","DOI":"10.1136\/spcare-2022-004088"},{"key":"2025062705050659000_15.4.526.4","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1097\/CCO.0b013e3283622c47","article-title":"Palliative sedation in end of-life care","volume":"25","author":"Maltoni","year":"2013","journal-title":"Curr Opin Oncol"},{"key":"2025062705050659000_15.4.526.5","doi-asserted-by":"crossref","first-page":"2811","DOI":"10.1007\/s00520-021-06685-w","article-title":"Pattern and characteristics of patients admitted to a Hospice connected with an acute palliative care unit in a comprehensive cancer center","volume":"30","author":"Mercadante","year":"2022","journal-title":"Support Care Cancer"},{"key":"2025062705050659000_15.4.526.6","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.jpainsymman.2020.09.022","article-title":"Clinical aspects of palliative sedation in prospective studies","volume":"61","author":"Arantzamendi","year":"2021","journal-title":"J Pain Symptom Manage"},{"key":"2025062705050659000_15.4.526.7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpainsymman.2007.12.024"},{"key":"2025062705050659000_15.4.526.8","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1016\/j.jpainsymman.2018.08.018","article-title":"Hyoscine Butylbromide for the management of death rattle: sooner rather than later","volume":"56","author":"Mercadante","year":"2018","journal-title":"Journal of Pain and Symptom Management"},{"key":"2025062705050659000_15.4.526.9","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0157300","article-title":"Supportive care unit in a comprehensive cancer center as Crossroad for patients\u2019 Oncological pathway","volume":"11","author":"Mercadante","year":"2016","journal-title":"PLoS ONE"},{"key":"2025062705050659000_15.4.526.10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpainsymman.2008.04.020"},{"key":"2025062705050659000_15.4.526.11","doi-asserted-by":"publisher","DOI":"10.1136\/spcare-2022-004085"},{"key":"2025062705050659000_15.4.526.12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpainsymman.2005.03.016"},{"key":"2025062705050659000_15.4.526.13","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S1470-2045(15)00401-5","article-title":"Effect of continuous deep sedation on survival in patients with advanced cancer (J-Proval): a propensity score-weighted analysis of a prospective cohort study","volume":"17","author":"Maeda","year":"2016","journal-title":"The Lancet Oncology"},{"key":"2025062705050659000_15.4.526.14","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/S1470-2045(20)30307-7","article-title":"Neuroleptic strategies for terminal agitation in patients with cancer and delirium at an acute palliative care unit: a single-centre, double-blind, parallel-group, randomised trial","volume":"21","author":"Hui","year":"2020","journal-title":"The Lancet Oncology"}],"container-title":["BMJ Supportive &amp; Palliative Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/spcare-2023-004669","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,27]],"date-time":"2025-06-27T12:05:44Z","timestamp":1751025944000},"score":1,"resource":{"primary":{"URL":"https:\/\/spcare.bmj.com\/lookup\/doi\/10.1136\/spcare-2023-004669"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,28]]},"references-count":14,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2025,6,27]]},"published-print":{"date-parts":[[2025,7]]}},"alternative-id":["10.1136\/spcare-2023-004669"],"URL":"https:\/\/doi.org\/10.1136\/spcare-2023-004669","relation":{},"ISSN":["2045-435X","2045-4368"],"issn-type":[{"value":"2045-435X","type":"print"},{"value":"2045-4368","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,28]]}}}